Two patients developed permanent postoperative atrioventricular block requiring insertion of a pacemaker.
In addition, 9% of patients died, 9% developed seizures, and 18% had significant postoperative infections.
Importantly, no unique technical issues relative to deployment were found in the immediate postoperative period, although complications can occur.
Postoperative injection at the site of the anastomosis between the homograft and the pulmonary arteries shows dilatation of the homograft with pulmonary regurgitation.
The effects of delirium on postoperative functional status were assessed in conjunction with postoperative depressive symptoms using regression models.
Our report discusses policies for postoperative prophylaxis as well as treatment of the acute thrombosis, including thrombolytic therapy with tissue plasminogen activator.
Five of these patients had suffered intraoperative or postoperative problems or had a re-operation.
One (7.1%) died during the early postoperative period (30 days), while the other died shortly after discharge from hospital.
